Nano-hesperetin ameliorates ۶-hydroxydopamine-induced behavioral deficits and oxidative damage by up-regulating gene expression of antioxidant enzymes

  • سال انتشار: 1402
  • محل انتشار: مجله گیاهان دارویی ابن سینا، دوره: 13، شماره: 3
  • کد COI اختصاصی: JR_AJP-13-3_007
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 124
دانلود فایل این مقاله

نویسندگان

Akbar Hajizadeh Moghaddam

Department of Animal Sciences, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran

Sara Alizadeh

Department of Animal Sciences, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran

Monireh Nejadi

Department of Animal Sciences, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran

Seyed Reza Mokhtari Sangdehi

Department of Animal Sciences, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran

Mahboobeh Zare

Faculty of Herbs, Amol University of Special Modern Technologies, Amol, Iran

Mojtaba Ranjbar

Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran

چکیده

Objective: Hesperetin (Hst) has shown several pharmacological effects. The efficacy of Hst is highly restricted in vivo due mainly to poor bioavailability. This investigation was intended to compare the influence of Hst and nano-Hst treatment on ۶-hydroxydopamine (۶-OHDA)-induced behavioral deficits and oxidative stress in rats.Materials and Methods: Forty-two Wistar male rats were equally assigned to ۶ groups: control, ۶-OHDA, Hst۵, Hst۱۰, nano-Hst۵, and nano-Hst۱۰. Treatment with Hst and nano-Hst was initiated ۱ day after the intrastriatal injection of ۶-OHDA and continued for ۲۸ days. Behavioral deficits were evaluated using apomorphine-induced rotation test (AIRT), narrow beam test (NBT) and novel object recognition test (NORT), and the hippocampus and striatum were used to evaluate oxidative stress-related parameters.Results: The rats injected only with ۶-OHDA showed learning and memory deficits but Hst and nano-Hst treatments improved it (p< ۰.۰۰۱). Compared to the control group, a marked promotion in Malondialdehyde (MDA) levels along with a marked reduction in activities and gene expression of antioxidant enzymes and reduced glutathione (GSH) levels in the hippocampus and striatum were observed in the ۶-OHDA group (p< ۰.۰۱). However, administration of Hst and nano-Hst remarkably diminished MDA levels (p< ۰.۰۱), and significantly increased the activities (p< ۰.۰۱) and gene expression of antioxidant enzymes (p< ۰.۰۵) and GSH levels (p< ۰.۰۱) compared to the ۶-OHDA group. In most parameters, nano-Hst has shown better therapeutic effects than Hst.Conclusion: Our findings reveal that Hst can be considered as a potential candidate for the treatment of neurodegenerative diseases and that nano-Hst may have better bioavailability.

کلیدواژه ها

Antioxidant Enzymes, Behavioral disorders, Nano-hesperetin, Parkinson’s disease, ۶-hydroxydopamine

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.